Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:617-622
Published online before print January 31, 2002, doi: 10.1161/01.ATV.0000012268.84961.AD
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
22/4/617    most recent
01.ATV.0000012268.84961.ADv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zanetti, A.
Right arrow Articles by Dejana, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zanetti, A.
Right arrow Articles by Dejana, E.
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Other Vascular biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:617.)
© 2002 American Heart Association, Inc.


Vascular Biology

Vascular Endothelial Growth Factor Induces Shc Association With Vascular Endothelial Cadherin

A Potential Feedback Mechanism to Control Vascular Endothelial Growth Factor Receptor-2 Signaling

Adriana Zanetti; Maria Grazia Lampugnani; Giovanna Balconi; Ferruccio Breviario; Monica Corada; Luisa Lanfrancone; Elisabetta Dejana

From the Mario Negri Institute of Pharmacological Research (A.Z., M.G.L., G.B., F.B., M.C., E.D.), Milan; the FIRC Institute of Molecular Oncology (M.G.L., F.B., M.C., E.D.), Milan; the European Institute of Oncology (L.L.), Milan; and the Dipartimento di Scienze Cliniche e Biologiche (E.D.), Facoltà di Medicina e Chirurgia, Università dell’Insubria, Varese, Italy.

Correspondence to Elisabetta Dejana, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milan, Italy. E-mail dejana{at}marionegri.it

Vascular endothelial (VE)-cadherin is endothelium specific, mediates homophilic adhesion, and is clustered at intercellular junctions. VE-cadherin is required for normal development of the vasculature in the embryo and for angiogenesis in the adult. Here, we report that VE-cadherin is associated with VE growth factor (VEGF) receptor-2 (VEGFR-2) on the exposure of endothelial cells to VEGF. The binding parallels receptor phosphorylation on tyrosine residues, which is maximal at 5 minutes and then declines within 30 minutes. Tyrosine phosphorylation of VE-cadherin was maximal at 30 minutes after the addition of the growth factor. At this time point, the protein could be coimmunoprecipitated with the adaptor protein Shc. Pull-down experiments with different Shc domains and mutants of the VE-cadherin cytoplasmic tail have shown that Shc binds to the carboxy-terminal domain of the VE-cadherin tail through its Src homology 2 domain (SH2). We found that Shc phosphorylation lasts longer in endothelial cells carrying a targeted null mutation in the VE-cadherin gene than in VE-cadherin–positive cells. These data suggest that VE-cadherin expression exerts a negative effect on Shc phosphorylation by VEGFR-2. We speculate that VE-cadherin binding to Shc promotes its dephosphorylation through associated phosphatases.


Key Words: endothelium • vascular endothelial cadherin • Shc




This article has been cited by other articles:


Home page
JCBHome page
Y. Liu, D. T. Sweet, M. Irani-Tehrani, N. Maeda, and E. Tzima
Shc coordinates signals from intercellular junctions and integrins to regulate flow-induced inflammation
J. Cell Biol., October 23, 2008; 182(1): 185 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E. Dejana, F. Orsenigo, and M. G. Lampugnani
The role of adherens junctions and VE-cadherin in the control of vascular permeability
J. Cell Sci., July 1, 2008; 121(13): 2115 - 2122.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Nakamura, N. Patrushev, H. Inomata, D. Mehta, N. Urao, H. W. Kim, M. Razvi, V. Kini, K. Mahadev, B. J. Goldstein, et al.
Role of Protein Tyrosine Phosphatase 1B in Vascular Endothelial Growth Factor Signaling and Cell-Cell Adhesions in Endothelial Cells
Circ. Res., May 23, 2008; 102(10): 1182 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Vestweber
VE-Cadherin: The Major Endothelial Adhesion Molecule Controlling Cellular Junctions and Blood Vessel Formation
Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 223 - 232.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B.-J. Pyun, S. Choi, Y. Lee, T.-W. Kim, J.-K. Min, Y. Kim, B.-D. Kim, J.-H. Kim, T.-Y. Kim, Y.-M. Kim, et al.
Capsiate, a Nonpungent Capsaicin-Like Compound, Inhibits Angiogenesis and Vascular Permeability via a Direct Inhibition of Src Kinase Activity
Cancer Res., January 1, 2008; 68(1): 227 - 235.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
Z. Ma, D. P. Myers, R. F. Wu, F. E. Nwariaku, and L. S. Terada
p66Shc mediates anoikis through RhoA
J. Cell Biol., October 8, 2007; 179(1): 23 - 31.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
T. Y. El Sayegh, P. D. Arora, K. Ling, C. Laschinger, P. A. Janmey, R. A. Anderson, and C. A. McCulloch
Phosphatidylinositol-4,5 Bisphosphate Produced by PIP5KI{gamma} Regulates Gelsolin, Actin Assembly, and Adhesion Strength of N-Cadherin Junctions
Mol. Biol. Cell, August 1, 2007; 18(8): 3026 - 3038.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. I. Lin, J. Yu, T. Murata, and W. C. Sessa
Caveolin-1-Deficient Mice Have Increased Tumor Microvascular Permeability, Angiogenesis, and Growth
Cancer Res., March 15, 2007; 67(6): 2849 - 2856.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Wang, G. Jin, H. Miao, J. Y.-S. Li, S. Usami, and S. Chien
Integrins regulate VE-cadherin and catenins: Dependence of this regulation on Src, but not on Ras
PNAS, February 7, 2006; 103(6): 1774 - 1779.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Sakurai, S. Fukuhara, A. Yamagishi, K. Sako, Y. Kamioka, M. Masuda, Y. Nakaoka, and N. Mochizuki
MAGI-1 Is Required for Rap1 Activation upon Cell-Cell Contact and for Enhancement of Vascular Endothelial Cadherin-mediated Cell Adhesion
Mol. Biol. Cell, February 1, 2006; 17(2): 966 - 976.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Lambeng, Y. Wallez, C. Rampon, F. Cand, G. Christe, D. Gulino-Debrac, I. Vilgrain, and P. Huber
Vascular Endothelial-Cadherin Tyrosine Phosphorylation in Angiogenic and Quiescent Adult Tissues
Circ. Res., February 18, 2005; 96(3): 384 - 391.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Bazzoni and E. Dejana
Endothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis
Physiol Rev, July 1, 2004; 84(3): 869 - 901.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M.-T. Lin, M.-L. Yen, C.-Y. Lin, and M.-L. Kuo
Inhibition of Vascular Endothelial Growth Factor-Induced Angiogenesis by Resveratrol through Interruption of Src-Dependent Vascular Endothelial Cadherin Tyrosine Phosphorylation
Mol. Pharmacol., November 1, 2003; 64(5): 1029 - 1036.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. G. Lampugnani, A. Zanetti, M. Corada, T. Takahashi, G. Balconi, F. Breviario, F. Orsenigo, A. Cattelino, R. Kemler, T. O. Daniel, et al.
Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, {beta}-catenin, and the phosphatase DEP-1/CD148
J. Cell Biol., May 26, 2003; 161(4): 793 - 804.
[Abstract] [Full Text] [PDF]